Marco Lolaico

Marco is a scientist with a PhD in Biophysics and over 5 years of experience across DNA nanotechnology, biomaterials development, and early-stage innovation. He has previously co-founded a biomaterials startup and he is the writer of the Plenty of Room newsletter. Plenty of Room brings emerging research in biotech, AI in biology, and DNA nanotech to a cross-disciplinary audience.

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Biotech treats DNA primarily as a coding material that provides information about disease phenotypes and can serve as a drug target and modality. But beyond the code, DNA is also an attractive programmable nanomaterial. By exploiting the predictability of Watson–Crick …

Marco Lolaico

Latest articles from Marco

Beyond the Code: How DNA Nanotechnology is Moving from Molecular Origami to Programmable Biotech Platforms